EcoDrugPlus

Glutamate Receptor, Ionotropic, Ampa 4b

Ensembl ID : ENSAPEG00000011689
Gene Symbol: GRIA4B
1 Cross references
252 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 1a

Ensembl ID : ENSAPEG00000017258
Gene Symbol: GRIN1A
1 Cross references
203 Possible Orthologues:

Glutamate Receptor, Metabotropic 2b

Ensembl ID : ENSAPEG00000011918
Gene Symbol: GRM2B
1 Cross references
210 Possible Orthologues:

Glutamate Receptor, Metabotropic 3

Ensembl ID : ENSAPEG00000013613
Gene Symbol: GRM3
1 Cross references
212 Possible Orthologues:

Glutamate Receptor, Metabotropic 5a

Ensembl ID : ENSAPEG00000021506
Gene Symbol: GRM5A
1 Cross references
212 Possible Orthologues:

Glutamate Receptor, Metabotropic 5b

Ensembl ID : ENSAPEG00000016973
Gene Symbol: GRM5B
1 Cross references
216 Possible Orthologues:

Glutaminase A

Ensembl ID : ENSAPEG00000005118
Gene Symbol: GLSA
1 Cross references
236 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha A

Ensembl ID : ENSAPEG00000015335
Gene Symbol: GSK3AA
1 Cross references
181 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha B

Ensembl ID : ENSAPEG00000010112
Gene Symbol: GSK3AB
1 Cross references
187 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta, Genome Duplicate A

Ensembl ID : ENSAPEG00000000490
Gene Symbol: GSK3BA
1 Cross references
208 Possible Orthologues:

Gonadotropin Releasing Hormone Receptor 1

Ensembl ID : ENSAPEG00000009072
Gene Symbol: GNRHR1
1 Cross references
173 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSAPEG00000024321
Gene Symbol: GHRHR
2 Cross references
193 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).